In the Press

Filters
Type
Sectors
Geography
Companies

Sign up for our free
equity research notes

Register
1641 Results
Embed
Matthew Read comments on trusts in Anthropic in Investors’ Chronicle

Matthew Read comments on trusts holding Anthropic in Holly McKechnie & Helen Kirrane’s article: “Managers will almost certainly weigh the company’s growth prospects against its valuation when they are looking to rebalance their portfolios down the line.. However, if Anthropic trades significantly above its pre-IPO valuation, or even grows, it stands to reason that managers […]

Matthew Read comments on SOI in Portfolio Adviser

Matthew Read comments on SOI’s results in Patrick Sanders’ article: “With Asian valuations still looking reasonable and signs that dividend growth is picking up across the region, there is plenty to be positive about, especially if the market rally broadens beyond technology.” Read more here

Investment trust insider on two Asian trusts

James Carthew: Two trusts striking the right balance in tech-heavy Asia Asian large cap indices are dominated by stocks perceived as AI winners. TSMC, Samsung and SK Hynix make up about a third of the MSCI All Countries Asia ex Japan index and Asia’s ten largest stocks comprised over 40% of that index. JPMorgan Asia […]

Investment Trust Insider on Perpetual Income and Growth
Richard Williams comments on SCF in Portfolio Adviser

Richard Williams comments on SCF’s results in Patrick Sanders’ article: “Solid absolute returns for SCF fell short of its benchmark gain, with weakness in consumer discretionary holdings proving a particular drag..More encouragingly, however, the trust delivered its 31st consecutive year of dividend growth and maintained its record of growing income ahead of inflation over the […]

David Batchelor comments on SMT’s update in Investment Week

David Batchelor comments on SMT’s technology exposure in Michael Nelson’s article: “The recent market nervousness over the scale and prospective returns from that spending will provide a fresh test of those positions, particularly with SMT’s five-year NAV return still well behind its benchmark.” Read more here

Biotech trusts top performance charts in February
Investment trust insider on City Natural Resources

James Carthew: The trust primed to ride the next commodities supercycle …That could be good news for the trusts that specialise in this area such as City Natural Resources (CYN). It is the best performing of the commodities and mining trusts over five years with a net asset value (NAV) return of 148%, well ahead […]

Investment Trust Insider on Perpetual Income and Growth
Matthew Read comments on INPP’s nuclear investment in Investors’ Chronicle

Matthew Read comments on the terms of INPP’s Sizewell investment in Val Cipriani’s article: “What particularly stood out was how much risk appeared to have been transferred away from private investors. Our main concern was whether the terms were almost too favourable, raising the possibility that a future government might seek to revisit them.” Read […]

Matthew Read comments on SHR in Investment Week

Matthew Read comments on the next leg of Shaires’ growth in Michael Nelson’s article: “Ultimately, Shaires will be judged on whether it can consistently secure attractive private investments at sensible valuations and convert that access into NAV-per-share growth,” Read more here

Biotech trusts top performance charts in February
Richard Williams comments on GRID sales announcement

Richard Williams comments on GRID putting itself up for sale in Michael Nelson’s article: “The timing is interesting given the substantial value that could still be unlocked through the development pipeline, with three projects totalling 777MW targeting final investment decisions next year that have the potential to generate further meaningful NAV uplifts.” Read more here

Matthew Read comments on changes at JAM

Matthew Read comments on the manager changes at JAM in Patrick Brusnahan’s article: “JAM’s board explicitly highlighted the benefits of having four managers, two overseeing growth and two value, when the arrangements were put in place and so it will be interesting to see if they are still comfortable with the reduced level of resource.” […]

Biotech trusts top performance charts in February